Cybin Therapeutics

The BC Bud Closes Initial Financing Tranche

The BC Bud Corporation (OTCQB: BCBCF) (CSE:BCBC) has closed an initial tranche of its non-brokered private placement. Gross proceeds of $52,500 were raised through the sale of 700,000 units at a price of $0.075 per unit.

Psyence, Filament Strike Magic Mushroom Product Licensing Agreement: What You Need To Know

Psyence Group (OTCQB: PSYGF) and Filament Health Corp. (OTCQB: FLHLF) announced the signing of a licensing agreement: Filament is to license its proprietary psilocybin derived drug, PEX010, and the associated IP to